BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28008571)

  • 1. Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.
    Focke CM; Decker T; van Diest PJ
    Ann Surg Oncol; 2017 May; 24(5):1251-1257. PubMed ID: 28008571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
    Tendl-Schulz KA; Rössler F; Wimmer P; Heber UM; Mittlböck M; Kozakowski N; Pinker K; Bartsch R; Dubsky P; Fitzal F; Filipits M; Eckel FC; Langthaler EM; Steger G; Gnant M; Singer CF; Helbich TH; Bago-Horvath Z
    Virchows Arch; 2020 Oct; 477(4):545-555. PubMed ID: 32383007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.
    Chen X; Sun L; Mao Y; Zhu S; Wu J; Huang O; Li Y; Chen W; Wang J; Yuan Y; Fei X; Jin X; Shen K
    BMC Cancer; 2013 Aug; 13():390. PubMed ID: 23957561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods.
    Focke CM; van Diest PJ; Decker T
    Breast Cancer Res Treat; 2016 Sep; 159(2):257-63. PubMed ID: 27558625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
    Chen X; Zhu S; Fei X; Garfield DH; Wu J; Huang O; Li Y; Zhu L; He J; Chen W; Jin X; Shen K
    BMC Cancer; 2015 Oct; 15():822. PubMed ID: 26514283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of the molecular subtype classification between core needle biopsy and surgical specimen in primary breast cancer.
    Pölcher M; Braun M; Tischitz M; Hamann M; Szeterlak N; Kriegmair A; Brambs C; Becker C; Stoetzer O
    Arch Gynecol Obstet; 2021 Sep; 304(3):783-790. PubMed ID: 33585986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core needle biopsy as an alternative to whole section in IHC4 score assessment for breast cancer prognostication.
    Liu M; Tang SX; Tsang JYS; Shi YJ; Ni YB; Law BKB; Tse GMK
    J Clin Pathol; 2018 Dec; 71(12):1084-1089. PubMed ID: 30228212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interlaboratory variability of Ki67 staining in breast cancer.
    Focke CM; Bürger H; van Diest PJ; Finsterbusch K; Gläser D; Korsching E; Decker T;
    Eur J Cancer; 2017 Oct; 84():219-227. PubMed ID: 28829990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.
    Shui R; Yu B; Bi R; Yang F; Yang W
    PLoS One; 2015; 10(5):e0125131. PubMed ID: 25932921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays.
    Knutsvik G; Stefansson IM; Aziz S; Arnes J; Eide J; Collett K; Akslen LA
    PLoS One; 2014; 9(11):e112121. PubMed ID: 25375149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literature.
    Kalvala J; Parks RM; Green AR; Cheung KL
    Histopathology; 2022 Feb; 80(3):468-484. PubMed ID: 34473381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate Molecular Classification of Invasive Breast Carcinoma: A Comparison Between Core Needle Biopsy and Surgical Excision, With and Without Neoadjuvant Therapy.
    Ambrosini-Spaltro A; Zunarelli E; Bettelli S; Lupi M; Bernardelli G; Milani M; Ficarra G
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):551-557. PubMed ID: 31335485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions.
    Focke CM; Decker T; van Diest PJ
    Histopathology; 2016 Dec; 69(6):1047-1054. PubMed ID: 27417415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in measuring the Ki-67 labeling index in patients with breast cancer.
    Yamamoto S; Chishima T; Mastubara Y; Adachi S; Harada F; Toda Y; Arioka H; Hasegawa N; Kakuta Y; Sakamaki K
    Clin Breast Cancer; 2015 Feb; 15(1):e35-9. PubMed ID: 25445422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
    Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
    PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminal A versus luminal B breast cancer: MammaTyper mRNA versus immunohistochemical subtyping with an emphasis on standardised Ki67 labelling-based or mitotic activity index-based proliferation assessment.
    Finsterbusch K; Decker T; van Diest PJ; Focke CM
    Histopathology; 2020 Apr; 76(5):650-660. PubMed ID: 31846096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Performance of Ki-67 Labeling Index in Different Specimen Categories of Invasive Ductal Carcinoma of the Breast Using 2 Scoring Methods.
    Al Nemer A
    Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):86-90. PubMed ID: 26509909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
    Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
    Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.